SecBot SecBot
DEFA14A ·Filed Mar 26, 2026

GRDN

Guardian Pharmacy Services, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago SEC0001193125-26-125073
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine governance filing. Traders should note the insider sell activity ($411.1M in 30 days) as a potential concern, but the proxy filing itself does not contain any material information that would immediately impact the stock price.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
GRDN ▲ +15.90% at T+60d
NEUTRAL call +15.90% · α vs SPY +1.95% · entry $35.40 → $41.03
Entry = T+0 close
Mar 26, 2026
via day close
T+1d
-3.50%
call -3.50% · α -1.82%
$34.16
settled 7mo ago
T+5d
+7.32%
call +7.32% · α +5.68%
$37.99
settled 7mo ago
T+20d
+6.13%
call +6.13% · α -4.54%
$37.57
settled 6mo ago
T+60d
+15.90%
call +15.90% · α +1.95%
$41.03
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Guardian Pharmacy Services, Inc. (GRDN) has filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled for May 5, 2026. The filing outlines four proposals: electing two Class II directors, approving executive compensation on an advisory basis, voting on the frequency of future say-on-pay votes, and ratifying Ernst & Young LLP as the independent auditor. The board recommends voting in favor of all proposals.

Key Facts

  • Annual Meeting of Stockholders scheduled for May 5, 2026.
  • Proposals include election of two Class II directors (John Ackerman and Randall Lewis), advisory approval of executive compensation, advisory vote on compensation frequency, and ratification of Ernst & Young LLP as auditor.
  • The board recommends voting FOR all proposals.
  • No material financial data, strategic changes, or activist involvement is disclosed in the filing.

Financial Impact

No direct financial impact from the proxy proposals themselves.

Risk Factors

  • High level of recent insider selling could indicate lack of confidence among executives or major shareholders.

Market Snapshot

Exchange
NYSE
Sector
Retail-Drug Stores and Proprietary Stores

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-125073
Document: 0001193125-26-125073-index-headers.html0001193125-26-125073
Document: 0001193125-26-125073-index.html0001193125-26-125073
Document: 0001193125-26-125073.txt0001193125-26-125073
9 reports for GRDN
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +12.52%May 6, 2026
Filters
Rows
Reports for GRDN — sortable, filterable
TypeNow
Aug 9, 2026
11w ago
Institutional Cluster
BULLISH ★ 4/10
$41.47 $42.45▲ +2.36%▲ +3.28%$39.19 (−5.50%)
Jun 22, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$39.19 $39.78▲ +1.51%▲ +0.35%$39.19 (−0.00%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$43.08 $41.06▼ −4.69%▼ −6.58%$39.19 (−9.03%)
May 28, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$38.74 $40.44▲ +4.39%▲ +6.18%$39.19 (+1.16%)
May 6, 2026
24w ago
S-3ASR
NEUTRAL ★ 3/10
$36.27 $39.14▲ +7.91%▲ +4.78%$39.19 (+8.05%)
May 6, 2026
24w ago
8-K
BULLISH ★ 6/10
$36.27 $39.14▲ +7.91%▲ +4.78%$39.19 (+8.05%)
Mar 26, 2026
30w ago
DEFA14A
NEUTRAL ★ 3/10
$35.40 $37.57▲ +6.13%▼ −4.54%$39.19 (+10.71%)
Mar 20, 2026
31w ago
Insider Cluster
BEARISH ★ 9/10
$35.62 $37.34▼ −4.83%▲ +4.49%$39.19 (−10.02%)
Feb 28, 2026
34w ago
Institutional Cluster
NEUTRAL ★ 5/10
$33.66 $37.25▲ +10.67%▲ +18.60%$39.19 (+16.43%)
Showing 9 of 9

US Market Status

Market Closed — Opens Tue (17h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 26, 2026